Global Chagas Disease Coalition
- Website
- https://www.coalicionchagas.org/
The Global Chagas Disease Coalition is an alliance of partners who have joined forces to promote access to diagnosis and treatment for patients with Chagas disease and to stimulate innovation in this field and the development of new tools to fight the disease.
Although international guidelines recommend that patients with Chagas disease should be treated, only 1% of those affected currently have access to treatment. This deplorable situation is the reason why the mobilization of efforts to increase access to treatment is so urgent, and the Coalition's aim is to play a central role in driving the agenda and achieving this goal.
In addition to its five founding members —ISGlobal, Drugs for Neglected Diseases initiative (DNDi), Fundación Mundo Sano, CEADES and the Sabin Vaccine Institute—the Coalition hopes to incorporate more institutions interested in joining this alliance against Chagas disease and has recently welcomed two new members—the Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center and the Nhepacha network.
Learn More
Projects
NHEPACHA
New Tools for the Diagnosis and Evaluation of Chagas Disease
Other projects
See Past ProjectsNHEPACHA
New Tools for the Diagnosis and Evaluation of Chagas Disease
RTS,S Vaccine Immunology Study
Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a Phase III double-blind, randomized, controlled multi-center trial
Euroleish.net
Control of Leishmaniasis. From bench to bedside and community
GREPIMER
Grup de recerca en patología importada i malaties emergents i re-emergents
TESEO
New chemotherapy regimens and biomarkers for Chagas Disease
ASINTMAL
Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults
ADAM
Malaria mass and focal drug administration to advance malaria elimination in Mozambique: accelerating programmatic implementation and policy translation
MULTIPLY
MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention
Science4Pandemics
Citizens engagement digital platform for collective intelligence in pandemics
HIDDENVIVAX
Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria
Subclinical Infections in Children and Long Term Health Effects
Infection acquisition in early life and health outcomes in childhood - MARATO TV3
Herramienta innovadora de detección de enfermedades y vacunación a población inmigrante en riesgo en España
Project Code: PI21/00651
Impacto de las coinfecciones en el balance de respuestas de anticuerpos y linfocitos T helper a antígenos diana de inmunidad natural y vacunal frente a patógenos humanos prominentes
Project Code: PI20/00866
EpiGen
Building Scalable Pathogen Genomic Epidemiology in Ethiopia
MalTransc
Transcriptional regulation of adaptation and developmental decisions in malaria parasites: from epigenetic variation to directed transcriptional responses
BOHEMIA
Broad One Health Endectocide-based Malaria Intervention in Africa
RESPONSE
Mechanisms of the transcriptional responses to changes in the environment in the malaria parasite Plasmodium falciparum
VivaxEVTalk
Extracellular Vesicles as Intercellular Communicators and Biomarkers of Cryptic Erythrocytic Infections in Plasmodium vivax malaria
VaMonoS
Unravelling the heterogoneity and function of monocytes in vaccination and immunity to malaria
CLIMSOCTRYPBOL
Insight on climate and social participatory research for integral management of vectorborne zoonosis caused by Trypanosoma cruzi and Leishmania spp. in the Bolivian Gran Chaco.
SexMal
Social affairs and sex in P. falciparum: implications for malaria elimination
MENA Migrant Health
Transforming data collection and surveillance to drive migrant health research, care and policy
MESA
Sharing knowledge and catalyzing research towards a malaria-free world
GenMoz
P. falciparum genomic intelligence in Mozambique
SMART
Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test